These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15913108)

  • 1. [Fighting against viral hepatitis B and C: which policy for prevention?].
    Jullien-Depradeux AM; Le Quellec-Nathan M; Postel-Vinay N; Coquin Y; Dab W
    Rev Prat; 2005 Mar; 55(6):585-6. PubMed ID: 15913108
    [No Abstract]   [Full Text] [Related]  

  • 2. [Viral hepatitis. Prevention, screening and research].
    de la Brière A
    Soins; 2013 Nov; (780):19. PubMed ID: 24409608
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic viral hepatitis B and C. Epidemiology, diagnosis, etiology, prevention].
    Castera L; Dhumeaux D; Pawlotsky JM
    Rev Prat; 2001 Jun; 51(11):1247-57. PubMed ID: 11503496
    [No Abstract]   [Full Text] [Related]  

  • 4. Consensus statements on the prevention and management of hepatitis B and hepatitis C in the Asia-Pacific region. Core Working Party for Asia-Pacific Consensus on Hepatitis B and C.
    J Gastroenterol Hepatol; 2000 Aug; 15(8):825-41. PubMed ID: 11022822
    [No Abstract]   [Full Text] [Related]  

  • 5. Transforming strategies for the prevention of chronic HBV and HCV infections.
    Ward JW; Hu DJ; Alter MJ; Kanwal F; Taylor C; Block JM; Caballero JB; Chase D; Saly M; Sandt L; Swan T
    J Fam Pract; 2010 Apr; 59(4 Suppl):S23-8. PubMed ID: 20398587
    [No Abstract]   [Full Text] [Related]  

  • 6. Transforming the current infrastructure for combating HBV and HCV infections.
    Kim WR; Ward JW; Cheever LW; Dan C; Dee L; Zola J
    J Fam Pract; 2010 Apr; 59(4 Suppl):S65-70. PubMed ID: 20398593
    [No Abstract]   [Full Text] [Related]  

  • 7. The dawn of a new era: transforming our domestic response to hepatitis B & C.
    El-Serag H; Lok AS; Thomas DL
    Gastroenterology; 2010 Apr; 138(4):1225-30, 1230.e1-3. PubMed ID: 20176024
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccines and immunotherapies against hepatitis B and hepatitis C viruses.
    Inchauspé G; Michel ML
    J Viral Hepat; 2007 Nov; 14 Suppl 1():97-103. PubMed ID: 17958650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic viral hepatitis as a public health issue in the world.
    Lavanchy D
    Best Pract Res Clin Gastroenterol; 2008; 22(6):991-1008. PubMed ID: 19187863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of hepatitis virus infections.
    Alter HJ
    Haemophilia; 2008 Jul; 14 Suppl 3():26-32. PubMed ID: 18510518
    [No Abstract]   [Full Text] [Related]  

  • 11. Meeting of the International Task Force for Disease Eradication, June 2017.
    Wkly Epidemiol Rec; 2017 Sep; 92(37):537-56. PubMed ID: 28914042
    [No Abstract]   [Full Text] [Related]  

  • 12. A National Strategy for the Elimination of Viral Hepatitis Emphasizes Prevention, Screening, and Universal Treatment of Hepatitis C.
    Buckley GJ; Strom BL
    Ann Intern Med; 2017 Jun; 166(12):895-896. PubMed ID: 28384754
    [No Abstract]   [Full Text] [Related]  

  • 13. [Incidence of infectious hepatitis in the Russian Federation and sociomedical measures to prevent its prevalence].
    Onishchenko GG
    Vestn Ross Akad Med Nauk; 2001; (8):31-4. PubMed ID: 11552622
    [No Abstract]   [Full Text] [Related]  

  • 14. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
    Schott E; Bergk A; Berg T
    Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Institute of Medicine report on viral hepatitis: a call to action.
    Sanyal AJ;
    Hepatology; 2010 Mar; 51(3):727-8. PubMed ID: 20198626
    [No Abstract]   [Full Text] [Related]  

  • 16. Overview of the viral hepatitis problem.
    Lok AS; Kim WR; El-Serag HB; Maddrey WC
    J Fam Pract; 2010 Apr; 59(4 Suppl):S11-6. PubMed ID: 20398585
    [No Abstract]   [Full Text] [Related]  

  • 17. Control of hepatitis B and C worldwide.
    Aggarwal R; Goel A
    BMJ; 2009 Oct; 339():b4431. PubMed ID: 19864363
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis B and C in children.
    Hsu EK; Murray KF
    Nat Clin Pract Gastroenterol Hepatol; 2008 Jun; 5(6):311-20. PubMed ID: 18414457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner.
    Miller DS; Kotlarski I; Jilbert AR
    Virology; 2006 Jul; 351(1):159-69. PubMed ID: 16624364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Funding the elimination of viral hepatitis: donors needed.
    Gore C; Hicks J; Deelder W
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):843-845. PubMed ID: 29100843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.